GRA Venture Fund sells minority interest in AKESOgen to Tempus Labs

Clients GRA Venture Fund, LLC and GRA Venture Fund (T.E.), LLC

Jones Day represented GRA Venture Fund, LLC and GRA Venture Fund (T.E.), LLC in connection with the sale of a minority interest in AKESOgen, a provider of premier research services and the highest quality data for scientists doing clinical or basic research across the world, to Tempus Labs.